Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis

Journal of Clinical Investigation

Volumn 114, Issue 7, 2004, Pages 898-907

  Watanabe, Kazuhide ^a   Hasegawa, Yasuhiro ^a   Yamashita, Hiroshi ^a   Shimizu, Kazue ^a   Ding, Yuanying ^a   Abe, Mayumi ^a   Ohta, Hideki ^b   Imagawa, Keiichi ^b,d   Hojo, Kanji ^c   Maki, Hideo ^c   Sonoda, Hikaru ^b   Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b Diagnostic Science Division   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

^d NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; COMPLEMENTARY DNA; RECOMBINANT PROTEIN; SECRETORY PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASOHIBIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL MIGRATION; CELL PROLIFERATION; DNA MICROARRAY; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOMA; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; AUTOCRINE COMMUNICATION; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEEDBACK, BIOCHEMICAL; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 9644262535     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200421152     Document Type: Article

References (34)

1. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27-31.
2. Ribatti, D., Vacca, A., and Presta, M. 2000. The discovery of angiogenic factors: a historical review. Gen. Pharmacol. 35:227-231.
3. Ferrara, N. 2002. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer. 2:795-803.
4. Good, D.J., et al. 1990. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. U. S. A. 87:6624-6628.
5. Dameron, K.M., Volpert, O.V., Tainsky, M.A., and Bouck, N.P. 1994. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 265:1582-1584.
6. Tombran-Tink, J., Chader, G.G., and Johnson, L.V. 1991. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res. 53:411-414.
7. Dawson, D.W., et al. 1999. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 285:245-248.
8. Ferrara, N., Clapp, C., and Weiner, R. 1991. The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology. 129:896-900.
9. O'Reilly, M.S., et al. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:315-328.
10. O'Reilly, M.S., et al. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:277-285.
11. Cao, Y., Chen, C., Weatherbee, J.A., Tsang, M., and Folkman, J. 1995. gro-β, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J. Exp. Med. 182:2069-2077.
12. Strieter, R.M., Kunkel, S.L., Arenberg, D.A., Burdick, M.D., and Polverini, P.J. 1995. Interferon γ-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem. Biophys. Res. Commun. 210:51-57.
13. Maione, T.E., et al. 1990. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science. 247:77-79.
14. Yancopoulos, G.D., et al. 2000. Vascular-specific growth factors and blood vessel formation. Nature. 407:242-248.
15. Lord, B.I. 1988. Feedback regulators in normal and tumour tissues. J. Cell Sci. Suppl. 10:231-242.
16. Sargiannidou, L., Zhou, J., and Tuszynski, G.P. 2001. The role of thrombospondin-1 in tumor progression. Exp. Biol. Med. 226:726-733.
17. Doll, J.A., et al. 2003. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat. Med. 9:774-780.
18. Folkman, J. 2002. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 6:15-18.
19. Abe, M., and Sato, Y. 2001. cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis. 4:289-298.
20. Kanno, S., et al. 2000. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene. 19:2138-2146.
21. Pugh, C.W., and Ratcliffe, P.J. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9:677-684.
22. Harris, A.L. 2002. Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer. 2:38-47.
23. Key, M.E. 1983. Macrophages in cancer metastases and their relevance to metastatic growth. Cancer Metastasis Rev. 2:75-88.
24. Kobayashi, Y., et al. 1990. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1α. Proc. Natl. Acad. Sci. U. S. A. 87:5548-5552.
25. Watanabe, N., and Kobayashi, Y. 1994. Selective release of a processed form of interleukin 1α. Cytokine. 6:597-601.
26. Wilson, K.P., et al. 1994. Structure and mechanism of interleukin-1β converting enzyme. Nature. 370:270-275.
27. Oikawa, M., et al. 2001. Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem. Biophys. Res. Commun. 289:39-43.
28. Ohta, H., et al. 1999. One-step direct assay for mature-type adrenomedullin with monoclonal antibodies. Clin. Chem. 45:244-251.
29. Iwasaka, C., Tanaka, K., Abe, M., and Sato, Y. 1996. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J. Cell. Physiol. 169:522-531.
30. Tanaka, K., Oda, N., Iwasaka, C., Abe, M., and Sato, Y. 1998. Induction of Ets-1 in endothelial cells during re-endothelialization after denuding injury. J. Cell. Physiol. 176:235-244.
31. Miyashita, H., et al. 2002. A mouse orthologue of puromycin-insensitive leucyl-specific aminopeptidase is expressed in endothelial cells and plays an important role in angiogenesis. Blood. 99:3241-3249.
32. Ogawa, S., et al. 1999. Induction of macrophage inflammatory protein-1alpha and vascular endothelial growth factor during inflammatory neovascularization in the mouse cornea. Angiogenesis. 3:327-334.
33. Nakano, T., et al. 2000. Angiogenesis inhibition by transdominant mutant Ets-1. J. Cell. Physiol. 184:255-262.
34. Schughart, K., and Accart, N. 2003. Use of adenovirus vectors for functional gene analysis in the chicken chorioallantoic membrane. Biotechniques. 34:178-183.